Clinical Trials Browser

Phase 1 × Melanoma × bryostatin 1 × Clear all

NCT00006022 2015-12-14

Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer

Phase 1 Completed

DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

NCT00112476 2013-05-03

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma